A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)

NCT06177912 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

882

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL: V116
BIOLOGICAL: PPSV23

Sponsor

Merck Sharp & Dohme LLC